AAPS 2009: Innovations-Neotanshinlactone Derivatives

A Joint Presentation of Pharmaceutical Technology and

Young Innovators of 2009: Interviews with AAPS Graduate Student Winners

Neotanshinlactone Derivatives

Subscribe to RSS feed of this series

Yizhou Dong
University of North Carolina, Chapel Hill

Category: DRUG DESIGN AND DISCOVERY

Design, Synthesis, and Biological Evaluation of Novel Neotanshinlactone Derivatives as Potent and Selective Anti-Breast Cancer Agents

View Poster Presentation

Related Articles

• Repairing the Engine of Drug Innovation

• Gauging Innovation in Pharmaceutical Development and Manufacturing

Winning Presentations

Listen to the Interviews

• Selectivity Studies

• Manufacturing Science and Engineering

• Drug Transport by Genetic Variants

• Drug and GeneDelivery Systems

• Chemogenomics

• Hepatic Transport Proteins

• Sustained Release, Microspheres

• Antimetastatic Lead Phenylmethylene Hydantoins

• Neotanshinlactone Derivatives

• Crystallization in Frozen Systems

• On-Line Microfluidic Extraction

• PSMA Inhibitor as a Homing Device

• Sorafenib Treatments

AAPS President

Dr. Patrick P. DeLuca, president of AAPS, discusses the organization’s programs and commitment to student scientists.

Listen>>